Bringing the Oncology Community Together

Login | Register
Home Nurses Urology Targeted Therapies Interactive Meetings OncLive TV Blogs Hennessy's Highlights Publications
December 2011
Features
Overcoming Resistance to Endocrine Therapies
The Year's New Drugs: Integrating Advances of 2011 Into Treatment Plans
New FDA-Approved Oncology Drugs and Indications, 2011
Avastin Increases PFS in Patients With Ovarian Cancer
Statins linked to lower risk of prostate cancer mortality in middle-aged men

From the Editor
Pharmacogenomics in Action: CYP2D6 Breast Cancer Debate Shows Intricacies of Genotyping

News & Opinion
Doxil Shortage Expected to Last Another Year

Pathways
Targeted Cancer Therapies: Awakening the "Guardian of the Genome"
5 Questions on the Development of p53

Profiles in Research
Keeping Patients in Mind: Noted Breast Cancer Researcher Pursues Broad Notion of Personalized Medicine

Specialty Focus
Radium-223 Properties Conducive to mCRPC Care
NICE's Reluctance to Back Yervoy Turns on Cost-Benefit Perceptions
FISH Testing Guides Treatment of CLL: New Drugs on Horizon
Minimally Invasive Surgeries Retain Place in Treatment Plan
Hematologic Congress Spotlights Major Issues, Emerging Research
Study Supports Smaller Margins in Excising Thicker Melanomas
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?